Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RandomizEd Trial of reVascularizAtion With Solitaire FR® Device Versus Best mediCal Therapy in the Treatment of Acute Stroke Due to anTerior Circulation Large Vessel Occlusion Presenting Within 8 Hours of Symptom Onset

NCT01692379 is registered in ClinicalTrials.gov with Fundacio Ictus Malaltia Vascular as lead sponsor.

NCT NCT01692379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01692379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RandomizEd Trial of reVascularizAtion With Solitaire FR® Device Versus Best mediCal Therapy in the Treatment of Acute Stroke Due to anTerior Circulation Large Vessel Occlusion Presenting Within 8 Hours of Symptom Onset
Lead sponsor
Fundacio Ictus Malaltia Vascular
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2012
Completion date
December 31, 2015
Enrollment
206 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke